Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia

Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil, +13

New England Journal of Medicine

Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia

Danilo Grünig Humberto da Silva, Edis Belini, Lidiane S. Torres, +4

Blood Cells Molecules and Diseases

Hydroxyurea TreatmentRedox SignalingHeme DegradationGeneticsHematology +5

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily

Timothy P. Hughes, Andreas Hochhaus, Hagop M. Kantarjian, +13

Haematologica

ENESTnd Update: Continued Superiority of Nilotinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP)

Timothy P. Hughes, Andreas Hochhaus, Giuseppe Saglio, +12

Blood

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

Giuseppe Saglio, Dong-Wook Kim, Surapol Issaragrisil, +13

Blood

ENESTnd 5-year (y) update: Long-term outcomes of patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with frontline nilotinib (NIL) versus imatinib (IM).

Richard A. Larson, Dong-Wook Kim, Saengsuree Jootar, +12

Journal of Clinical Oncology

Abnormal transcranial Döppler ultrasonography in children with sickle cell disease

Ana Claúdia Celestino Bezerra Leite, Raquel de Vasconcellos Carvalhães de Oliveira, Patrícia Moura, +2

Revista Brasileira de Hematologia e Hemoterapia

Treatment of the acute sickle cell vaso‐occlusive crisis in the Emergency Department: a Brazilian method of switching from intravenous to oral morphine

Jessica Campos, Clarisse Lobo, Ana Maria Mach Queiroz, +4

European Journal Of Haematology

Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study

Rodolfo Delfini Cançado, Nora Watman, Clarisse Lobo, +7

Hematology

Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload – the RELATH study

Clarisse Lobo, Ivan L. Ângulo, Lidia R Aparicio, +3

Hematology

ImmunohematologyIron MetabolismIron DeficiencyRelath StudyAnemia +23